Eleven scientists leading the way in stroke research will be recognized during the American Stroke Association's International Stroke Conference 2024 for their exceptional professional achievements.

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company currently focused on developing recombinant KLK1 (DM199) for the treatment of acute ...

"Assessing Safety and Clinical Outcomes of Rinvecalinase Alfa (DM199) in Acute Ischemic Stroke Patients Pre-treated with Intravenous Thrombolytics Only" Expand The poster is P-704. On Thursday May 22, ...

Combining clinical, translational and basic research, the meeting brought together a network of leading professionals who are working to better understand stroke pathophysiology, develop effective ...

Patients can have a variety of symptoms when experiencing an ischemic stroke, caused by a clot blocking a blood vessel in the brain. Doctors choose whether to treat the stroke with clot-busting ...

Dr Annie J. Ferris explores how stroke survivors are finding hope and resilience through the healing power of creativity and ...

There are many venues in which to present your research findings, both within BCM and at external conferences. Your research mentor is likely to be an excellent source of information regarding ...